» Articles » PMID: 34853346

Identifying Occult Bladder Outlet Obstruction in Women with Detrusor-underactivity-like Urodynamic Profiles

Overview
Journal Sci Rep
Specialty Science
Date 2021 Dec 2
PMID 34853346
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Voiding dysfunction can result from detrusor underactivity (DU), bladder outlet obstruction (BOO), or both. Conceptually, women with high-pressure low-flow urodynamic profiles are diagnosed with BOO without DU. However, the possibility of BOO is often neglected in women with DU-like (low-pressure low-flow) urodynamic (UDS) profiles. By reviewing the videourodynamic studies (VUDS) of 1678 women, our study identified the key factors suggesting urodynamic BOO (determined by radiographic evidence of obstruction) in women with DU-like UDS profiles (Pdet.Qmax < 20 cmH2O and Qmax < 15 mL/s). In 355 women with DU-like UDS profiles, there were 70 (19.7%) with BOO and 285 (80.3%) without BOO. The BOO group had predominantly obstructive symptoms. The BOO group showed significantly decreased bladder sensation, lower detrusor pressure (Pdet.Qmax), lower flow rate (Qmax), smaller voided volume, and larger post-voiding residual (PVR) compared to the non-BOO group. In multivariate analysis, volume at first sensation, Qmax, PVR, and detrusor overactivity (DO) remained independent factors for BOO. The receiver operating characteristic (ROC) areas for the parameters were largest for PVR (area = 0.786) and Qmax (area = 0.742). The best cut-off points were 220 mL for PVR and 4 mL/s for Qmax. Our findings provide simple indicators for BOO in women with DU.

Citing Articles

Analysis of clinical efficacy of sacral magnetic stimulation for the treatment of detrusor underactivity.

Pan H, Tang C, Song C, Li J Front Neurol. 2025; 16:1499310.

PMID: 40070670 PMC: 11893392. DOI: 10.3389/fneur.2025.1499310.


Prevalence and predictors of detrusor underactivity and bladder outlet obstruction in women with lower urinary tract symptoms.

Wu C, Hsiao S, Wu P, Chang T, Chen C, Sheu B Sci Rep. 2024; 14(1):25141.

PMID: 39448651 PMC: 11502903. DOI: 10.1038/s41598-024-76242-y.


Diagnoses and Treatment Recommendations-Interrater Reliability of Uroflowmetry in People with Multiple Sclerosis.

Jaekel A, Rieger J, Butscher A, Mohr S, Schindler O, Queissert F Biomedicines. 2024; 12(7).

PMID: 39062170 PMC: 11274854. DOI: 10.3390/biomedicines12071598.


Botulinum Toxin A Injection for Autonomic Dysreflexia-Detrusor Injection or Urethral Sphincter Injection?.

Chow P, Kuo H Toxins (Basel). 2023; 15(2).

PMID: 36828422 PMC: 9961697. DOI: 10.3390/toxins15020108.

References
1.
King A, Goldman H . Bladder outlet obstruction in women: functional causes. Curr Urol Rep. 2014; 15(9):436. DOI: 10.1007/s11934-014-0436-z. View

2.
Choi Y, Kim J, Lee K, Seo J, Kim H, Yoo T . Analysis of female voiding dysfunction: a prospective, multi-center study. Int Urol Nephrol. 2013; 45(4):989-94. DOI: 10.1007/s11255-013-0475-2. View

3.
Resnick N, Yalla S, Laurino E . The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med. 1989; 320(1):1-7. DOI: 10.1056/NEJM198901053200101. View

4.
Boyd K, Hilas O . α-adrenergic blockers for the treatment of lower-urinary-tract symptoms and dysfunction in women. Ann Pharmacother. 2014; 48(6):711-22. DOI: 10.1177/1060028014524174. View

5.
Nitti V, Tu L, Gitlin J . Diagnosing bladder outlet obstruction in women. J Urol. 1999; 161(5):1535-40. View